The 2024 ASAP BioPharma Conference is the leading life science alliance and partnering event for professionals in all stages of their career from new learners to senior leaders.
This must-attend program presents rich content over two days addressing alliance management topical areas such as:
- Skill Building
- Demonstrating Value
- Situational Leadership
Attendees learn from leaders and practitioners within the biopharma alliance community sharing their wisdom, experiences, and best practices. Gain industry insights impacting strategic partnering on what's remained the same, what's changed, and what's on the radar.
CONFERENCE CO-CHAIRS
Suzanne Collins
Head, Strategy & Operations,
R&D Strategy & External Innovation
Takeda
Stefan Walke, CA-AM, PhD
Global Head of Alliance Management
Boehringer Ingelheim
WHY ATTEND?
Leading Life Science Event
on alliances and partnerships
Two Full Days
of interactive learning
30 Sessions
focused on new, experienced, and advanced learners
Professional Connections
10 meals, breaks, and receptions
1:1 and 1:Small Group
coaching / mentoring / sharing
Diverse Representation
among attendees and companies
CONFERENCE SPONSORS
ASAP would like to thank the following companies for their support of the community and this conference.
Platinum Sponsor
Gold Sponsors
WHO'S ATTENDED?
2seventy bio
Abbott
AbbVie
AbCellera
Absci Corporation
Actalent Services
Adimab
AffaMed Therapeutics
Alexion Pharmaceuticals
Alliance Partnership Consulting LLC
allianceboard
American Type Culture Collection
Amgen, Inc.
Arrowhead Pharma
Astellas
AstraZeneca
Atara Biotherapeutics
Beam Therapeutics
BeiGene
Biogen
BioNTech
Biotechnology Innovation Organization
Boehringer Ingelheim
Boston Children's Hospital
Bristol-Myers Squibb
BTD Consulting
C4 Therapeutics
Calico Life Science
Cancer Research Horizons
Carberry Consulting
CAS
Click Therapeutics
Cytokinetics, Inc.
Daiichi Sankyo, Inc.
Dalton Psychological Services
Dana-Farber Cancer Institute
Dicerna Pharmaceuticals
Dyno Therapeutics
Eli Lilly and Company
EQRx
Equipro International
Exelixis, Inc
Flagship Pioneering
Galapagos
Genmab
Gilead Sciences
Ginkgo Bioworks
GSK-GlaxoSmithKline
H. Lee Moffitt Cancer Center & Research Institute
Harmony Biosciences
IAVI
Illumina, Inc.
ImmunoGen, Inc.
Incyte
Integrated Alliance Management
Intellia Therapeutics
IPM (Integrated Project Management, Inc.)
Ipsen
Jazz Pharmaceuticals
Johnson & Johnson Innovative Medicine
Kite Pharma Inc.
Legend Biotech
Life Edit
Marinus Pharmaceuticals
Merck
Merck Healthcare KGaA
Merus
Moderna
MorphoSys
Mycovia Pharmaceuticals
NewCo
Novartis
Novo Nordisk
Nurix Therapeutics
Optum at Home
Orbital Therapeutics
Orchard Therapeutics
Orion Corporation
Otsuka Pharmaceuticals
Pfizer
Pierre Fabre Medicament
Precede BioSciences
Puma Biotechnology
Repare Therapeutics
ResistanceBio
Sandoz
Sanofi
Scorpion Therapeutics
Scottish Development International
Seres Therapeutics
Servier
Simcere Pharmaceutical Group
SMPA Pharmaceuticals
Spark Therapeutics, Inc.
SpringWorks Therapeutics
Sumitomo Pharma America
Symbix Consultoria
Takeda Pharmaceuticals
Terns Pharmaceuticals
Teva Pharmaceuticals
The Rhythm of Business
Tune Therapeutics
University of Illinois Chicago
University of Southern California
Upsher-Smith Laboratories, LLC
Urovant Sciences
VALNEVA SE
Vantage Partners
Vir Biotechnology
Wave Life Sciences
X-Chem Inc.
Zealand Pharma